While the data provides interesting observations, they do not demonstrate causation. The authors compare two intervention areas with one control area. The main problem is that one intervention area had similar results to the control area, while the other intervention area had very different results. I therefore think that it is unwise to just combine the two sets of data for the intervention areas as, there seem to be very different things going on. Thus the data for all areas should be reported separately, with confidence intervals quoted throughout.
While there is an attempt to provide some explanation for the differences between Lewisham and Lambeth on page 7 lines 17-25, this does not provide sufficient plausible explanation for the size of difference between the two intervention areas. I am left thinking that something else must be going on in Lewisham that led to such significant reductions -for example were there other interventions within primary or secondary care? or was this just down to artefact? I would expect these to have been explored further, before make claims such as "introducing community based enhanced services can reduce the pressure on secondary care providers, particularly as a result of reduced referrals from primary care" (page 7 lines 40-42).
There are other perplexing aspects of the data. The description on page 4 lines 24-43 of the MECs service (which I would have put in the introduction rather than the methods section) suggests that it is intended for a conditions such as red eye, sticky eye, watery eye, flashers, floaters etc. However, the data on hospital referrals will be for referrals for eye ophthalmological conditions, eg including cataract, glaucoma, AMD etc. Data on reasons for referral to hospital care is poor, and hence the authors would not have been able to assess whether the significant reduction in Lewisham also impacted on referrals on cataract etc which seems implausible, yet this might need to be the case to achieve an overall 15.6% reduction in referrals.
It was also not clear to me why there might all be a reduction in follow-up appointments for patients originally referred by a GP. Is the suggestion that the MECS is somehow also influencing hospital management procedures? This seems implausible, unless the change in case mix is in some way influencing things. The problem is that the authors do not consider this. Similarly why did referrals from other hospital consultants and other sources also reduce. How did the MECS influence these? All of these questions suggest that a more plausible reason for the reduction in Lewisham was a change in some other service change or artefact.
In the methods section (p5 line 37-39) the authors say that there were three commissioning areas with populations served by three hospitals, giving nine hospital commissioning area combinations. I presume that the MECS were operating at commissioning area level, thus it would have been possible to see if there were differences between referrals into the three hospitals for Lewisham GPs. It may be that Lewisham GPs mainly referred into just one of the hospitals. However, if there referrals pathways were roughly equal, it would have been interesting to see if reductions were significantly greater in just one of the hospitals. this might help disentangle where there reductions were due to the MECS or due to some other reason. A similar analysis should have been done for Lambeth and Southwark, to again support/disprove such a hypothesis.
The authors state (p4 4 lines 51-54) that they have MECS data for the presenting eye condition, the number of patients referred for onward hospital based ophthalmology and the main types of treatments given. While there is always a challenge writing a paper within the word count, given this is BMJ Open, this will be less of an issue, and I would have liked to have seen these data included. In particular the onward hospital referral data is important. Significant cost savings will only result if the higher hospital tariff can be averted, and hence if significant numbers of MECS patients need to be referred on then there will be no time saving for patients (indeed these will be increased if they just have to join another waiting list) and the commissioner will also need to pay the MECS tariff AND the hospital tariff. These data would also not capture any patients who are dissatisfied with the outcome of the MECS treatment and present back at the GP (increasing GP workload) or who have then to be referred by the GP to hospital, or patients who self refer by an eye A&E. That said, the analysis that the authors have conducted would capture any GPs referral made by GPs after patients have been seen by the MECS.
In summary, whilst this is interesting data, the loose ends and unanswered questions mean that I cannot support publication in its current format. However, with addition of suitable caveats and exploration of artefacts etc, a paper based on these data may be suitable for publication. A few major comments regarding methodology and statistics:
REVIEWER
- Table 1 : What justified the choice of these specific characteristics?
Research evidence suggests that differences in health care utilisation normally exist across gender, age and levels of educational attainment. Frequently reported results show that health services demand is higher amongst women than men and that health risks increase with age and thus so health care consumption. Why were age and gender not included? Also, the areas do seem similar but was there any testing for statistically significant differences?
- The discussion of the change in hospital attendances in the main text is a bit misleading as it compares different quarters (quarter starting September 2011 with the quarter finishing in August 2014) when it"s possible there is a seasonal effect and, also, when you actually compare the same quarters before and after the introduction of the ITS (say 03/13 to 08/13 with 03/14 to 08/14) you get a 2.5% increase for Lambeth, 2.6% decrease for Lewisham and 6.7% increase for Southwark. You mention a 15.6% decrease in Lewisham but the biggest part of that decrease happened in the quarter just before the introduction of the ITS.
- Table 3 : There is a distinct lack of statistical information regarding the modelling both in the table and in the text. What was the model used, OLS? What was the justification for the choice of a natural log for the volume of outpatient attendances? What were the coefficients and CI for the other model variables? How many observations? How robust are the results, no measure of goodness of fit is provided?
- Table 4 and table 5 : The interpretation of these tables is very misleading as it discusses the changes in costs without taking into account the changes in the total number of patients seen both by Hospital Ophthalmology and ITS. Lambeth"s costs increased by 2.5% but considering that there was an increase in the total volume of patients of 6.5% (from 33224 to 35397) there was actually net cost savings. Lewisham"s costs decreased 13.8% but a considerable part of that has to be attributed to the decrease of 8.1% in the total volume of patients from 28774 to 26447. Regarding Southwark, although the volume of patients increased 5.1% the cost only increased 3.1% because the less costly type of appointment (followup) increased whilst the most costly (first) decreased. Maybe a relative measure such as change in cost per patient would be clearer.
Methodology: the DD method assumes that the outcome (patients treated) in the so called treatment and control groups would have followed a common trend in the absence of the policy (introduction of ITS) and therefore any deviations from the common trend are caused by the policy. If the numbers in table 4 are added so we have total numbers of patients seen in the different areas we have the results which are in the table attached.
With the introduction of ITS we would expect not a change in the total volume of patients seen but instead a transfer of patients from hospital ophthalmology to ITS as the purpose of the policy is to reduce demand in secondary care by providing replacement services at lower costs. Arguably, a small increase in the total number of patients seen could be expected, caused by the fact ITS are potentially easier to access. But for the DD method to work we would expect similar trends in all the areas in terms of total patients and that is not what we have. Lambeth saw increases in both first and follow-up patients, Lewisham saw decreases for both type of appointments and the control area of Southwark saw the number of first appointments decrease while follow-ups increased. The main problem with this paper is that the impression given to the reader that MECS should be introduced in other areas as a means of reducing hospital waiting times. For example on page 7 lines 4-6, "We found that referrals to hospitals from primary care were significantly reduced when enhanced services were introduced".
We have revised the language in the appropriate sections in order to make clear we do not imply a definitive causal effect (conclusion in abstract; final paragraph in discussion) and we continue to avoid any discussion of waiting times throughout the paper. We also include the point we make in the "strengths and limitations" section that emphasises that the results may not be generalizable to other parts of the UK in the discussion section.
As noted above, we have revised the language in the appropriate sections in order to make clear we do not imply a definitive causal effect (conclusion in abstract; final paragraph in discussion).
We have now constructed the difference-in-differences analysis so that estimates are reported for each of the main providers in each of the intervention areas. This allows the reader to see where the effect(s) are concentrated rather than reporting the mean effect. We include standard errors in tables and give the confidence intervals where effects are quoted in the text.
Members of the research team were present at all meetings of the Lambeth, Lewisham and Southwark CCG "Eye Group" which was responsible for ophthalmic service delivery initiatives during the period and conducted interviews with the participant CCGs. There were no other policy changes or care pathway initiatives during this period. We have now clarified this in the sixth paragraph of the discussion (lines 5-6).
There are other perplexing aspects of the data. The description on page 4 lines 24-43 of the MECs service (which I would have put in the introduction rather than the methods section)
We have now moved the section describing the MECS into the introduction as suggested.
suggests that it is intended for a conditions such as red eye, sticky eye, watery eye, flashers, floaters etc. However, the data on hospital referrals will be for referrals for eye ophthalmological conditions, e.g. including cataract, glaucoma, AMD etc. Data on reasons for referral to hospital care is poor, and hence the authors would not have been able to assess whether the significant reduction in Lewisham also impacted on referrals on cataract etc which seems implausible, yet this might need to be the case to achieve an overall 15.6% reduction in referrals.
We now include the data that we have on the % of patients retained in the community vs. referred to hospital stratified by the optometrists" provisional diagnosis. (Table 6 ). It is clear from the data in Table 6 that MECS resulted in a number of cases of cataract, suspect glaucoma, retinal and choroidal disease, and extra-ocular muscle abnormalities etc. from reaching the HES. These total several hundred cases but are unlikely to make a significant contribution to the overall 15.6% reduction in referrals.
We have now constructed the difference-in-differences analysis so that estimates are reported for each of the main providers in each on the intervention areas. We can rule out the possibility that the MECS is somehow influencing hospital management procedures on the basis that we do not see the same effect repeated for both intervention areas for (for example) Hospital B.
It may be possible that direct referral into the appropriate sub specialist ophthalmology clinic would reduce consultant to consultant referrals. We think that the key point is that, despite an increase in consultant to consultant referrals during the period, ophthalmology activity reduced in Lewisham overall
We have now constructed the difference-in-differences analysis so that estimates are reported for each of the main providers in each on the intervention areas.
Differences in how the enhanced services were structured and used between the two intervention areas may offer possible explanations for the variation in the estimated effects. The Lewisham scheme was concentrated in just five optometry practices, while eight practices participated in Lambeth and rates of utilisation varied substantially. There was a difference between the two areas in the referral sources into MECS, with approximately 56% of all patients seen in Lambeth referred by a GP compared to 75% in Lewisham. Finally, there was much higher level of GP engagement in the scheme in Lewisham: 90% of GP practices registered compared with 78% in Lambeth.
We have included these possibilities as a paragraph in the discussion section.
The authors state (p4 4 lines 51-54) that they have MECS data for the presenting eye condition, the number of patients referred for onward hospital based ophthalmology and the main types of treatments given. While there is always a challenge writing a paper within the word count, given this is BMJ Open, this will be less of an issue, and I would have liked to have seen these data included. In particular the onward hospital referral data is important.
We now include the data that we have on the % of patients retained in the community vs. referred to hospital stratified by the optometrists" provisional diagnosis. (Table 6 ). We have also included data on the reason for presenting for a MECS evaluation, together with data on how these patients were managed in MECS (Table 7 ).
Significant cost savings will only result if the higher hospital tariff can be averted, and hence if significant numbers of MECS patients need to be referred on then there will be no time saving for patients (indeed these will be increased if they just have to join another waiting list) and the commissioner will also need to pay the MECS tariff AND the hospital tariff.
We now include the data that we have on the % of patients retained in the community vs. referred to hospital stratified by the optometrists" provisional diagnosis. (Table 6 ). We have also included data on the reason for presenting for a MECS evaluation, together with data on how these patients were managed in MECS (Table 7) .
A high proportion of MECS patients are retained in the community, of whom a considerable proportion have no eye disease (Tables 6 and 7) . Although we have no data on patients who might be subsequently referred by their GP to the HES or who self-refer to A&E after their MECS evaluation, it is likely that the majority of these patients will not reach the HES as a result of this episode and so will avoid the higher hospital tariff. Recently published qualitative research on MECS revealed a very high degree of satisfaction among patients with the scheme which suggests only a minority of patients would be likely to re-present at HES clinics. We have included the preceding as a paragraph in the Discussion section of our re-submitted paper.
These data would also not capture any patients who are dissatisfied with the outcome of the MECS treatment and present back at the GP (increasing GP workload) or who have then to be referred by the GP to hospital, or patients who self refer by an eye A&E. That said, the analysis that the authors have conducted would capture any GPs referral made by GPs after patients have been seen by the MECS.
We agree that the model would capture these GP referrals. Please see the response above and the new paragraph included in the Discussion section of the resubmitted paper. We have now emphasised the importance of GP engagement to maximise the potential for success of similar schemes (final sentence of the Discussion)
In summary, whilst this is interesting data, the loose ends and unanswered questions mean that I cannot support publication in its current format. However, with addition of suitable caveats and exploration of artefacts etc, a paper based on these data may be suitable for publication. This is an easy to read and an interesting piece of work. Using an example of enhanced eye care services it highlights the changes in healthcare utilisation after health services re-configuration. I do not see any major issues in this paper. My comments are minor and are as follows:
13.8% in the other intervention area". I think this paragraph is the repetition of the results already described in the "Results" section in page 6. I do not see any reason why these results are to be repeated here in the "Discussion" section.
We have now changed this section (based on comments from reviewer 1). We do still summarise the main results in the discussion on the basis that this is common practice, but we are happy to change this based on editorial advice.
Page 7, lines 28: "It is possible that the changes in patient volumes............factors other than the ITS". Could you please report some likely factors? For example:
The intervention and comparator areas share borders and have similar population characteristics, which has helped to match confounders. However, these boroughs are geographically very close and the results in the intervention area may have been contaminated by patients from outside the study boroughs attending the MECS directly without a GP referral. It is also likely that patients from the neighbouring comparison area (Southwark) may have attended the MECS into the neighbouring intervention area (Lewisham and Lambeth). This could have contributed to increased utilisation in the intervention areas. Please report if this was checked and there was no chance of patients attending MECS from other boroughs other than the intervention boroughs.
Unfortunately it was not possible for the number of patients who may have attended MECS from Southwark to be determined. However, the proportion is likely to be small and would not impact the conclusions from the current analysis in any substantive way.
Page 7: Last paragraph .." Although we do not know the effect on final patient outcomes.......". Research conducted in this area of work is very little, so it would be good mentioning about potential future research example: cost effectiveness of MECS.
We have inserted a sentence on future research (patient outcomes and cost-effectiveness) in the final sentence of the sixth paragraph of the discussion.
The findings of this study may not necessarily generalizable across other settings. Though this has been mentioned in the summary "strength and limitations" in the front page of the manuscript, it is not mentioned anywhere in the Discussion section. Please add this in the discussion section.
We have added this caveat in the penultimate sentence of the penultimate paragraph.
Reviewer: 3 Reviewer Name: Patricia Norwood Institution and Country: Health Economics Research Unit, University of Aberdeen, UK Competing Interests: None declared I think the paper is well written and addresses an interesting and important question.
A minor comment regards the discussing of other studies. The objective of trying to reduce demand on secondary care by transferring care to other providers is not exclusive to England and in Scotland, for instance, it was recognised in 2006 that some patients attending hospital eye departments could be dealt with in the community and as such free eye examinations are now offered by eye street optometry practices. The paper would benefit from framing this policy in the "This change has led to the development of enhanced eye service schemes (community optometric services) across the UK, which allow for the treatment and management of acute eye care conditions by accredited optometrists in non-hospital settings. GOS provision is not identical across the UK. Notably in Scotland, where a new GOS contract has been in operation since April 2006. Among the differences that apply in Scotland compared with the rest of the UK, a supplementary eye examination on a glaucoma suspect could be performed in Scotland under the GOS contract, however this would fall outside the GOS in the rest of the UK."
A few major comments regarding methodology and statistics: Table 1 : What justified the choice of these specific characteristics? Research evidence suggests that differences in health care utilisation normally exist across gender, age and levels of educational attainment. Frequently reported results show that health services demand is higher amongst women than men and that health risks increase with age and thus so health care consumption. Why were age and gender not included? Also, the areas do seem similar but was there any testing for statistically significant differences?
We have now included age and gender characteristics of our intervention and comparison areas (Table 1) . We include the characteristics for the reasons the author sets out -that use of health services typically varies by these characteristics. The discussion of the change in hospital attendances in the main text is a bit misleading as it compares different quarters (quarter starting September 2011 with the quarter finishing in August 2014) when it"s possible there is a seasonal effect and, also, when you actually compare the same quarters before and after the introduction of the ITS (say 03/13 to 08/13 with 03/14 to 08/14) you get a 2.5% increase for Lambeth, 2.6% decrease for Lewisham and 6.7% increase for Southwark. You mention a 15.6% decrease in Lewisham but the biggest part of that decrease happened in the quarter just before the introduction of the ITS.
We have amended Table 2 to stratify by type of attendance as suggested. We now compare over the same calendar time point in the main text in replacement of the previous comparison (first paragraph of results). The ITS was introduced in April 2013 -MECS data were not collected until September 2013 based on a consideration that the MECS would require a 6 month bedding in period. However, we think it is appropriate for the intervention to be dated at April 2013 and we have amended accordingly. We have now included more detail on the statistical modelling. We now state in the methods section that we estimate the model using OLS and that we use the natural logarithm in order to be able to simply express relative (percentage) changes in volume.
We have now constructed the difference-in-differences analysis so that estimates are reported for each of the main providers in each on the intervention areas. This allows the reader to see where the effect(s) are concentrated rather than reporting the mean effect.
We include standard errors in tables and give the confidence intervals where effects are quoted in the text. We also now include the N and adjusted R-squared in Table 3 for each model. Table 4 and table 5 : The interpretation of these tables is very misleading as it discusses the changes in costs without taking into account the changes in the total number of patients seen both by Hospital Ophthalmology and ITS. Lambeth"s costs increased by 2.5% but considering that there was an increase in the total volume of patients of 6.5% (from 33224 to 35397) there was actually net cost savings. Lewisham"s costs decreased 13.8% but a considerable part of that has to be attributed to the decrease of 8.1% in the total volume of patients from 28774 to 26447. Regarding Southwark, although the volume of patients increased 5.1% the cost only increased 3.1% because the less costly type of appointment (follow-up) increased whilst the most costly (first) decreased. Maybe a relative measure such as change in cost per patient would be clearer.
In Table 4 we show the volume(s) of patients at hospital and at the ITS before and after the introduction of the ITS, and we attach (fixed) unit costs to these. In terms of hospital activity, changes in costs are wholly attributable to changes in volume as the unit costs are fixed. We also show the volume and unit cost at the ITS. Hopefully this enables the reader to ascertain the impact on total costs that result from changes in hospital activity and the introduction of ITS activity. These total costs are then summarised in Table 5 .
With the introduction of ITS we would expect not a change in the total volume of patients seen but instead a transfer of patients from hospital ophthalmology to ITS as the purpose of the policy is to reduce demand in secondary care by providing replacement services at lower costs. Arguably, a small increase in the total number of patients seen could be expected, caused by the fact ITS are potentially easier to access. But for the DD method to work we would expect similar trends in all the areas in terms of total patients and that is not what we have. Lambeth saw increases in both first and follow-up patients, Lewisham saw decreases for both type of appointments and the control area of Southwark saw the number of first appointments decrease while follow-ups increased. The big drop in numbers in Lewisham (almost a quarter less patients seen) raises questions regarding what other factors might be at play there when the drop was much smaller in Southwark and numbers actually increased in Lambeth. Faced with these facts, is DD a suitable method to analyse these data?
In Table 2 , we show the patterns of activity in the three commissioning areas over time. In terms of the total number of patients, in the period prior to the introduction of the MECS (09/11 until 02/13), we actually observe an increase in total volume in each of the three commissioning areas (from 16,557 to 17,207 in Lambeth; from 13,676 to 15,348 in Lewisham; and from 13,826 to 14,780 in Southwark).
In line with the comments of reviewer 1 and with this particular comment in mind, we have sought to soften the language used throughout the paper and make clear that we cannot be clear as to whether we find a casual effect. We do think that the DiD setup is useful in this paper, and it allows us to show estimates of differential change(s) when comparing the two intervention areas with the comparison area; and to provide confidence intervals etc. We also now provide effects for each providercommissioner combination, to illustrate where effects were particularly concentrated. We also state in the discussion section that "It is possible that the changes in patient volumes in the areas that introduced an ITS were caused by factors other than the ITS. 
